Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

269988 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

69
70
71
72
73
... 18000

Send results to Selected: 0 Clear selection

Guo HH, Li CX, Yang M, Li FF, Yang HY, Yin M, Wang JP, Wang FS. Gentidelasides A-G: Loganin derivatives from Gentiana delavayi with reducing Aβ secretion via suppressing BACE1 expression. Phytochemistry. 2025 Feb;230:114333. Epub 2024 Nov 14 PubMed.

Wang J, Jiang N, Liu F, Wang C, Zhou W. Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting. Pharmacol Ther. 2025 Feb;266:108761. Epub 2024 Nov 26 PubMed.

Yuste MT, Sainz-Gil M, Escudero E, Marín P. Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). Pharmacol Res Perspect. 2025 Feb;13(1):e70075. PubMed.

Magavern EF, Deshmukh H, Asselin G, Theusch E, Trompet S, Li X, Noordam R, Chen YI, Seeman TE, Taylor KD, Post WS, Tardif JC, Paul DS, Benjamin EJ, Heard-Costa NL, Vasan RS, Rotter JI, Krauss RM, Jukema JW, Ridker PM, Munroe PB, Caulfield MJ, Chasman DI, Dubé MP, Hitman GA, Warren HR, Genomic Investigation of Statin Therapy Consortium (GIST). GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study. Pharmacol Res. 2025 Feb;212:107575. Epub 2025 Jan 9 PubMed.

Hu Y, Peng S, Xiao C. Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management. Pharmacol Res. 2025 Feb;212:107594. Epub 2025 Jan 10 PubMed.

Garcia-Zamora M, García-Lluch G, Moreno L, Cháfer-Pericas C, Pardo J. Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management. Pharmacol Res. 2025 Feb;212:107595. Epub 2025 Jan 9 PubMed.

Möller JE, Schmitt FW, Günther D, Stöver A, Bouter Y. The synthetic cannabinoid WIN 55,212-2 attenuates cognitive and motor deficits and reduces amyloid load in 5XFAD Alzheimer mice. Pharmacol Biochem Behav. 2025 Feb;247:173944. Epub 2024 Dec 13 PubMed.

Jain S, Singh R, Paliwal T, Verma K, Dwivedi J, Paliwal S, Sharma S. Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies. Pharmacol Biochem Behav. 2025 Feb;247:173943. Epub 2024 Dec 10 PubMed.

Godínez-Chaparro B, Rodríguez-Ramos MC, Martínez-Lorenzana MG, González-Morales E, Pérez-Ruíz KP, Espinosa de Los Monteros-Zuñiga A, Mendoza-Pérez F, Condes-Lara M. Pramipexole decreases allodynia and hyperalgesia via NF-κB in astrocytes in rats with Parkinson's disease. Pharmacol Biochem Behav. 2025 Feb;247:173945. Epub 2024 Dec 13 PubMed.

Aye S, Frisell O, Zetterberg H, Skillbäck TB, Kern S, Eriksdotter M, Aho E, Xia X, Winblad B, Wimo A, Jönsson L. Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study. Pharmacoeconomics. 2025 Feb;43(2):153-169. Epub 2024 Nov 1 PubMed.

Fruijtier AD, van der Flier WM, van Maurik I, van der Schaar J, Pijnenburg YA, Smets EM, Visser LN. The need for personalization when sharing results of amyloid imaging for Alzheimer's disease: Insights from a randomized experimental study. Patient Educ Couns. 2025 Feb;131:108587. Epub 2024 Nov 28 PubMed.

Tan JH, Laurell AA, Sidhom E, Rowe JB, O'Brien JT. The effect of Amyloid and Tau Co-pathology on disease progression in Lewy body dementia: A systematic review. Parkinsonism Relat Disord. 2025 Feb;131:107255. Epub 2024 Dec 24 PubMed.

López Domínguez D, Alemany Perna B, Álvarez Bravo G. Late-onset chorea as first manifestation of cerebral amyloid angiopathy. Parkinsonism Relat Disord. 2025 Feb;131:107225. Epub 2024 Dec 28 PubMed.

Kawabata K, Banno F, Mizutani Y, Maeda T, Nagao R, Shima S, Murayama K, Ohno Y, Maeda T, Sasaki M, Ueda A, Ito M, Watanabe H. Flattened red nucleus in progressive supranuclear palsy detected by quantitative susceptibility mapping. Parkinsonism Relat Disord. 2025 Feb;131:107251. Epub 2024 Dec 20 PubMed.

Hauser RA, Fernandez HH, Jimenez-Shahed J, Allard S, Banisadr G, Fisher S, D'Souza R. Duration of "Good On" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®). Parkinsonism Relat Disord. 2025 Feb;131:107239. Epub 2024 Dec 15 PubMed.

Go to another page:

69
70
71
72
73
... 18000

Current Filters

No filters selected

Filter By

Papers of the Week

Current Week (329)
7-13 Feb 2025 (410)
31 Jan - 6 Feb 2025 (295)
24-30 Jan 2025 (369)

Type ?

Milestone (286)
Alzforum Recommends (3829)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us